Four Weeks of a Neuro-Meditation Program Improves Sleep Quality and Reduces Hypertension in Nursing Staff During the COVID-19 Pandemic: A Parallel Randomized Controlled Trial

Hausswirth, C; Nesi, X; Dubois, A; Duforez, F; Rougier, Y; Slattery, K

Four Weeks of a Neuro-Meditation Program Improves Sleep Quality and Reduces Hypertension in Nursing Staff During the COVID-19 Pandemic: A Parallel Randomized Controlled Trial

Hausswirth, C Nesi, X Dubois, A Duforez, F Rougier, Y Slattery, K

Permalink

Publisher:: Frontiers Media SA
Publication Type:: Journal Article
Citation:: Frontiers in Psychology, 13

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (1.44 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Hausswirth, C
dc.contributor.author	Nesi, X
dc.contributor.author	Dubois, A
dc.contributor.author	Duforez, F
dc.contributor.author	Rougier, Y
dc.contributor.author	Slattery, K https://orcid.org/0000-0002-2879-5488
dc.date.accessioned	2022-05-28T11:51:13Z
dc.date.available	2022-05-28T11:51:13Z
dc.identifier.citation	Frontiers in Psychology, 13
dc.identifier.issn	1664-1078
dc.identifier.uri	http://hdl.handle.net/10453/157794
dc.description.abstract	<jats:p>The purpose of this study was to examine the effectiveness of a neuro-meditation program to support nurses during the COVID-19 pandemic. Forty-five (10 men and 35 women) nurses were classified into three groups based on their systolic blood pressure: normotensive (G-nor; <jats:italic>n</jats:italic> = 16, 43.8 ± 11.0 year), hypertensive (G-hyp; <jats:italic>n</jats:italic> = 13, 45.2 ± 10.7 year) and control (G-con; <jats:italic>n</jats:italic> = 16, 44.9 ± 10.6 year). Using a parallel, randomly controlled design across a 4-week period, 10 × 30-min sessions using the Rebalance© Impulse were completed. Sleep was assessed by wrist actigraphy and subjective sleep questionnaires; perceived sleep quality, Ford Insomnia Response to Stress Test questionnaire and the Spiegel Sleep Quality questionnaire (SSQ). Blood pressure, resting heart rate, mean heart rate (HRmean), heart rate variability index (RMSSD), cortisol, and alpha-amylase were also measured. Statistical analysis was completed using factorial ANOVA. Sleep improved in the G-hyp group; SSQ (<jats:italic>p</jats:italic> < 0.01); perceived sleep quality (<jats:italic>p</jats:italic> < 0.01); sleep efficiency and fragmentation index (<jats:italic>p</jats:italic> < 0.05). In the G-nor group, sleep was improved to a lesser extent; perceived sleep quality (<jats:italic>p</jats:italic> < 0.01). A significant time–group interaction was reported in resting heart rate (<jats:italic>p</jats:italic> < 0.01), systolic blood pressure (<jats:italic>p</jats:italic> < 0.01), and diastolic blood pressure (<jats:italic>p</jats:italic> < 0.05) with these measures being significantly reduced in the G-hyp group. RMSSD increased in the G-nor group (<jats:italic>p</jats:italic> < 0.01). This initial evidence suggests that neuro-meditation reduces excessive sympathetic activity, promoting enhanced sleep quality and autonomic control during periods of increased work-related stress.</jats:p><jats:sec><jats:title>Clinical Trial Registration</jats:title><jats:p>The study was conducted at Bioesterel, Sophia-Antipolis, France as a clinical trial: Neuro-meditation improves sleep quality, <jats:ext-link>https://www.drks.de/ui_data_web/DrksUI.html?locale=en</jats:ext-link>, DRKS00025731.</jats:p></jats:sec>
dc.language	en
dc.publisher	Frontiers Media SA
dc.relation.ispartof	Frontiers in Psychology
dc.relation.isbasedon	10.3389/fpsyg.2022.854474
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1701 Psychology, 1702 Cognitive Sciences
dc.title	Four Weeks of a Neuro-Meditation Program Improves Sleep Quality and Reduces Hypertension in Nursing Staff During the COVID-19 Pandemic: A Parallel Randomized Controlled Trial
dc.type	Journal Article
utslib.citation.volume	13
utslib.for	1701 Psychology
utslib.for	1702 Cognitive Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.date.updated	2022-05-28T11:51:12Z
pubs.publication-status	Published online
pubs.volume	13

Abstract:

The purpose of this study was to examine the effectiveness of a neuro-meditation program to support nurses during the COVID-19 pandemic. Forty-five (10 men and 35 women) nurses were classified into three groups based on their systolic blood pressure: normotensive (G-nor; n = 16, 43.8 ± 11.0 year), hypertensive (G-hyp; n = 13, 45.2 ± 10.7 year) and control (G-con; n = 16, 44.9 ± 10.6 year). Using a parallel, randomly controlled design across a 4-week period, 10 × 30-min sessions using the Rebalance© Impulse were completed. Sleep was assessed by wrist actigraphy and subjective sleep questionnaires; perceived sleep quality, Ford Insomnia Response to Stress Test questionnaire and the Spiegel Sleep Quality questionnaire (SSQ). Blood pressure, resting heart rate, mean heart rate (HRmean), heart rate variability index (RMSSD), cortisol, and alpha-amylase were also measured. Statistical analysis was completed using factorial ANOVA. Sleep improved in the G-hyp group; SSQ (p < 0.01); perceived sleep quality (p < 0.01); sleep efficiency and fragmentation index (p < 0.05). In the G-nor group, sleep was improved to a lesser extent; perceived sleep quality (p < 0.01). A significant time–group interaction was reported in resting heart rate (p < 0.01), systolic blood pressure (p < 0.01), and diastolic blood pressure (p < 0.05) with these measures being significantly reduced in the G-hyp group. RMSSD increased in the G-nor group (p < 0.01). This initial evidence suggests that neuro-meditation reduces excessive sympathetic activity, promoting enhanced sleep quality and autonomic control during periods of increased work-related stress.Clinical Trial RegistrationThe study was conducted at Bioesterel, Sophia-Antipolis, France as a clinical trial: Neuro-meditation improves sleep quality, https://www.drks.de/ui_data_web/DrksUI.html?locale=en, DRKS00025731.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/157794